Related Experiment Video

Updated: Aug 17, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Diabetic nephropathy, percutaneous coronary interventions, and blockade of the renin-angiotensin system

Holger Reinecke1, Fritz Matzkies, Manfred Fobker

  • 1Department of Cardiology and Angiology, Medical Clinic and Policlinic C, University Hospital of Munster, Munster, Germany. reinech@mednet.uni-muenster.de

Cardiology
|June 9, 2005
PubMed

Insights

Patients with diabetic nephropathy undergoing percutaneous coronary interventions (PCI) face significantly higher mortality. Angiotensin-converting enzyme inhibitors or receptor blockers may improve outcomes for these high-risk patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Diabetology

Background:

  • Percutaneous coronary interventions (PCI) outcomes are impaired in chronic renal failure.
  • The specific impact of diabetic nephropathy on PCI outcomes requires further investigation.

Purpose of the Study:

  • To analyze the outcomes of percutaneous coronary interventions (PCI) in patients with diabetic nephropathy.
  • To compare mortality rates in patients with diabetic nephropathy versus other renal insufficiency causes and controls.

Main Methods:

  • Retrospective analysis of 721 consecutive patients undergoing PCI.
  • Subgroup analysis based on diabetic nephropathy, diabetes alone, other renal insufficiency, and controls.
  • Comparison of angiographic success rates and 30-day and long-term mortality.

Main Results:

  • Diabetic nephropathy was present in 5.1% of patients.
  • Angiographic success rates were similar across subgroups (94-97%).
  • 30-day and 4-year mortality were significantly higher in diabetic nephropathy patients (8.1% and 27%) compared to other groups (p<0.001).

Conclusions:

  • Diabetic nephropathy significantly increases mortality after PCI.
  • Treatment with ACE inhibitors or ARBs was associated with reduced 2-year mortality in diabetic nephropathy patients.
  • These findings highlight the critical need for optimized cardiovascular care in diabetic nephropathy patients.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...